Supernus Pharmaceuticals
SUPN
#4296
Rank
S$2.67 B
Marketcap
$48.52
Share price
0.55%
Change (1 day)
36.43%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.06

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.05. In 2022 the company made an earnings per share (EPS) of $1.50 an increase over its 2021 EPS that were of $1.35.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.06-29.41%
2022$1.5010.78%
2021$1.35-57.68%
2020$3.2012.09%
2019$2.850.47%
2018$2.8489.38%
2017$1.50-38.59%
2016$2.44534.48%
2015$0.38-211.54%
2014-$0.34-91.1%
2013-$3.8739.46%
2012-$2.78-69.27%
2011-$9.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$25.61 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.20 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.26 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.94 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.67 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA